Related references
Note: Only part of the references are listed.Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study
Ilknur Tugal-Tutkun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2018)
Interleukin-1 blockade in neuro-Behcet's disease: a case-based reflection
Antonio Vitale et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh‡et's disease-related uveitis: a multicenter retrospective observational study
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2017)
Long-term efficacy and safety of anakinra in a patient with Behcet's disease and concomitant tuberculosis infection
Giacomo Emmi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study
Ilknur Tugal-Tutkun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner
Donato Rigante
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Quality of life impairment in Beh‡et's disease and relationship with disease activity: a prospective study
Claudia Fabiani et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Cytokine Signatures in Mucocutaneous and Ocular Behcet's Disease
Giuseppe Lopalco et al.
FRONTIERS IN IMMUNOLOGY (2017)
Efficacy and safety profile of anti-interleukin-1 treatment in Behcet's disease: a multicenter retrospective study
Giacomo Emmi et al.
CLINICAL RHEUMATOLOGY (2016)
Cutting Edge: IL-1 Receptor Signaling is Critical for the Development of Autoimmune Uveitis
Chi-Keung Wan et al.
JOURNAL OF IMMUNOLOGY (2016)
New therapeutic solutions for Behcet's syndrome
Antonio Vitale et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Behcet syndrome: the vascular cluster
Hasan Yazici et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2016)
High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
Elizabeth M. Gordon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
Isabelle Kone-Paut et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
Yasuka Matsunaga et al.
MEDIATORS OF INFLAMMATION (2015)
Successful treatment with canakinumab of a paediatric patient with resistant Behcet's disease
Ilaria Pagnini et al.
RHEUMATOLOGY (2015)
Anakinra treatment in drug-resistant Behcet's disease: a case series
Luca Cantarini et al.
CLINICAL RHEUMATOLOGY (2015)
Validation of the revised International Criteria for Behcet's Disease (ICBD) in Iran
Fereydoun Davatchi et al.
CLINICAL RHEUMATOLOGY (2015)
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behcet's Disease: A Case Series
Antonio Vitale et al.
DERMATOLOGY (2014)
Efficacy of Infliximab in Intestinal Behcet's Disease: A Korean Multicenter Retrospective Study
Jin Ha Lee et al.
INFLAMMATORY BOWEL DISEASES (2013)
Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
Antonio Vitale et al.
MEDIATORS OF INFLAMMATION (2013)
Behcet's Syndrome
Gulen Hatemi et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)
Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study
Ahmet Gul et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease
Serdal Ugurlu et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
BRIDGING THE GAP BETWEEN THE CLINICIAN AND THE PATIENT WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
L. Cantarini et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Resistant Behcet disease responsive to anakinra
Costantino Botsios et al.
ANNALS OF INTERNAL MEDICINE (2008)
Cross-cultural adaptation of the Behcet's disease current activity form (BDCAF) to Brazilian Portuguese language
F. S. Neves et al.
CLINICAL RHEUMATOLOGY (2007)
Hydrocephalus in CINCA syndrome treated with anakinra
D Rigante et al.
CHILDS NERVOUS SYSTEM (2006)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Share Paper
